Healthequity (HQY) Given Coverage Optimism Rating of 0.22

Headlines about Healthequity (NASDAQ:HQY) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Healthequity earned a news impact score of 0.22 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.2350742228284 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the news headlines that may have impacted Accern’s analysis:

Get Healthequity alerts: HealthEquity Inc. (HQY) VP Darcy G. Mott Cut 10000 Shares (bharatapress.com) Investors Love This Stock?: HealthEquity, Inc. (HQY) (bitcoinpriceupdate.review) Insider Selling: Healthequity Inc (HQY) Director Sells 15,000 Shares of Stock (americanbankingnews.com) Notable ETF Inflow Detected – IJT, STMP, HQY, TREX (nasdaq.com) You Need to Watch this stock? HealthEquity, Inc. (HQY) (connectinginvestor.com)

Several brokerages have issued reports on HQY. Barrington Research boosted their price target on shares of Healthequity to $85.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. They noted that the move was a valuation call. Oppenheimer boosted their price target on shares of Healthequity from $68.00 to $85.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. Robert W. Baird boosted their price target on shares of Healthequity from $61.00 to $77.00 and gave the company a “neutral” rating in a report on Tuesday, June 5th. SunTrust Banks boosted their price target on shares of Healthequity from $70.00 to $85.00 and gave the company a “buy” rating in a report on Tuesday, June 5th. Finally, KeyCorp boosted their price target on shares of Healthequity from $72.00 to $82.00 and gave the company an “overweight” rating in a report on Tuesday, June 5th. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $77.00.

HQY opened at $79.99 on Tuesday. Healthequity has a twelve month low of $40.21 and a twelve month high of $82.04. The stock has a market capitalization of $4.87 billion, a PE ratio of 148.13, a PEG ratio of 3.27 and a beta of 1.42.

Healthequity (NASDAQ:HQY) last posted its earnings results on Monday, June 4th. The company reported $0.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.09. Healthequity had a net margin of 22.91% and a return on equity of 13.47%. The business had revenue of $69.90 million for the quarter, compared to analyst estimates of $68.81 million. During the same quarter in the prior year, the firm earned $0.23 EPS. The firm’s quarterly revenue was up 26.2% compared to the same quarter last year. research analysts expect that Healthequity will post 0.72 earnings per share for the current year.

In other news, CMO Gary D. Robinson sold 500 shares of the company’s stock in a transaction dated Thursday, April 12th. The shares were sold at an average price of $64.00, for a total value of $32,000.00. Following the sale, the chief marketing officer now owns 3,490 shares of the company’s stock, valued at approximately $223,360. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Evelyn S. Dilsaver sold 15,000 shares of the company’s stock in a transaction dated Thursday, July 5th. The stock was sold at an average price of $77.46, for a total transaction of $1,161,900.00. Following the completion of the sale, the director now directly owns 28,193 shares in the company, valued at approximately $2,183,829.78. The disclosure for this sale can be found here. In the last ninety days, insiders sold 492,093 shares of company stock worth $34,125,002. 4.00% of the stock is owned by insiders.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.